193 related articles for article (PubMed ID: 30445275)
21. Behavioral activation and smoking cessation outcomes: The role of depressive symptoms.
Martínez-Vispo C; López-Durán A; Senra C; Rodríguez-Cano R; Fernández Del Río E; Becoña E
Addict Behav; 2020 Mar; 102():106183. PubMed ID: 31809878
[TBL] [Abstract][Full Text] [Related]
22. The impact of depressive symptoms on the efficacy of naltrexone in smoking cessation.
Walsh Z; Epstein A; Munisamy G; King A
J Addict Dis; 2008; 27(1):65-72. PubMed ID: 18551889
[TBL] [Abstract][Full Text] [Related]
23. Nicotine-Use/Smoking Is Associated with the Efficacy of Naltrexone in the Treatment of Alcohol Dependence.
Anton RF; Latham PK; Voronin KE; Randall PK; Book SW; Hoffman M; Schacht JP
Alcohol Clin Exp Res; 2018 Apr; 42(4):751-760. PubMed ID: 29431852
[TBL] [Abstract][Full Text] [Related]
24. Predictors of reduced smoking quantity among recovering alcohol dependent men in a smoking cessation trial.
Worley MJ; Isgro M; Heffner JL; Lee SY; Daniel BE; Anthenelli RM
Addict Behav; 2018 Sep; 84():263-270. PubMed ID: 29763835
[TBL] [Abstract][Full Text] [Related]
25. The impact of quitting smoking on depressive symptoms: findings from the International Tobacco Control Four-Country Survey.
Cooper J; Borland R; Yong HH; Fotuhi O
Addiction; 2016 Aug; 111(8):1448-56. PubMed ID: 26918680
[TBL] [Abstract][Full Text] [Related]
26. Supervised, Vigorous Intensity Exercise Intervention for Depressed Female Smokers: A Pilot Study.
Patten CA; Bronars CA; Vickers Douglas KS; Ussher MH; Levine JA; Tye SJ; Hughes CA; Brockman TA; Decker PA; DeJesus RS; Williams MD; Olson TP; Clark MM; Dieterich AM
Nicotine Tob Res; 2017 Jan; 19(1):77-86. PubMed ID: 27613946
[TBL] [Abstract][Full Text] [Related]
27. Reduction of anxiety sensitivity in relation to nicotine withdrawal symptoms during smoking cessation: an examination among successful quitters.
Bakhshaie J; Zvolensky MJ; Langdon KJ; Leventhal AM; Schmidt NB
Cogn Behav Ther; 2018 Jul; 47(4):301-314. PubMed ID: 29130427
[TBL] [Abstract][Full Text] [Related]
28. Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms.
Rohsenow DJ; Tidey JW; Martin RA; Colby SM; Swift RM; Leggio L; Monti PM
Addiction; 2017 Oct; 112(10):1808-1820. PubMed ID: 28498504
[TBL] [Abstract][Full Text] [Related]
29. Relationship between negative affect and smoking topography in heavy drinking smokers.
Green R; Bujarski S; Roche DJ; Ray LA
Addict Behav; 2016 Oct; 61():53-7. PubMed ID: 27240211
[TBL] [Abstract][Full Text] [Related]
30. Effects of nicotine dependence and depressive symptoms on smoking cessation: a longitudinal study among adolescents.
Scherphof CS; van den Eijnden RJ; Harakeh Z; Raaijmakers QA; Kleinjan M; Engels RC; Vollebergh WA
Nicotine Tob Res; 2013 Jul; 15(7):1222-9. PubMed ID: 23231824
[TBL] [Abstract][Full Text] [Related]
31. Effects of depressive symptoms on antecedents of lapses during a smoking cessation attempt: an ecological momentary assessment study.
Brodbeck J; Bachmann MS; Brown A; Znoj HJ
Addiction; 2014 Aug; 109(8):1363-70. PubMed ID: 24690068
[TBL] [Abstract][Full Text] [Related]
32. What a difference a day makes: differences in initial abstinence response during a smoking cessation attempt.
Piper ME; Vasilenko SA; Cook JW; Lanza ST
Addiction; 2017 Feb; 112(2):330-339. PubMed ID: 27633341
[TBL] [Abstract][Full Text] [Related]
33. Exercise and Counseling for Smoking Cessation in Smokers With Depressive Symptoms: A Randomized Controlled Pilot Trial.
Bernard P; Ninot G; Cyprien F; Courtet P; Guillaume S; Georgescu V; Picot MC; Taylor A; Quantin X
J Dual Diagn; 2015; 11(3-4):205-16. PubMed ID: 26683252
[TBL] [Abstract][Full Text] [Related]
34. Dimensions of depressive symptoms and smoking cessation.
Leventhal AM; Ramsey SE; Brown RA; LaChance HR; Kahler CW
Nicotine Tob Res; 2008 Mar; 10(3):507-17. PubMed ID: 18324570
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of sequential use of fluoxetine for smoking cessation in elevated depressive symptom smokers.
Brown RA; Abrantes AM; Strong DR; Niaura R; Kahler CW; Miller IW; Price LH
Nicotine Tob Res; 2014 Feb; 16(2):197-207. PubMed ID: 24057928
[TBL] [Abstract][Full Text] [Related]
36. Contingency management for cigarette smokers with depressive symptoms.
Secades-Villa R; Vallejo-Seco G; García-Rodríguez O; López-Núñez C; Weidberg S; González-Roz A
Exp Clin Psychopharmacol; 2015 Oct; 23(5):351-60. PubMed ID: 26280589
[TBL] [Abstract][Full Text] [Related]
37. Predictors of smoking cessation group treatment engagement among veterans with serious mental illness.
Travaglini LE; Li L; Brown CH; Bennett ME
Addict Behav; 2017 Dec; 75():103-107. PubMed ID: 28728038
[TBL] [Abstract][Full Text] [Related]
38. Relapse Rate and Factors Related to Relapse in a 1-Year Follow-Up of Subjects Participating in a Smoking Cessation Program.
Koçak ND; Eren A; Boğa S; Aktürk ÜA; Öztürk ÜA; Arınç S; Şengül A
Respir Care; 2015 Dec; 60(12):1796-803. PubMed ID: 26286738
[TBL] [Abstract][Full Text] [Related]
39. A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol.
Allen SI; Foulds J; Pachas GN; Veldheer S; Cather C; Azzouz N; Hrabovsky S; Hameed A; Yingst J; Hammett E; Modesto J; Krebs NM; Zhu J; Liao J; Muscat JE; Richie J; Evins AE
BMC Public Health; 2017 Jan; 17(1):100. PubMed ID: 28103841
[TBL] [Abstract][Full Text] [Related]
40. Smoking Decisions: Altered Reinforcement Learning Signals Induced by Nicotine State.
Baker TE; Zeighami Y; Dagher A; Holroyd CB
Nicotine Tob Res; 2020 Feb; 22(2):164-171. PubMed ID: 29982681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
